BlackRock’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
|
|||||
2020
Q1 | $213M | Sell |
|
|||||
2019
Q4 | $211M | Sell |
|
|||||
2019
Q3 | $111M | Buy |
|
|||||
2019
Q2 | $122M | Buy |
|
|||||
2019
Q1 | $71.1M | Buy |
|
|||||
2018
Q4 | $48.1M | Buy |
|
|||||
2018
Q3 | $37.1M | Buy |
|
|||||
2018
Q2 | $15.3M | Buy |
|
|||||
2018
Q1 | $6.12M | Buy |
|
|||||
2017
Q4 | $8.1M | Buy |
|
|||||
2017
Q3 | $9.4M | Buy |
|
|||||
2017
Q2 | $11.6M | Buy |
|
|||||
2017
Q1 | $7.35M | Buy |
|
|||||
2016
Q4 | $260K | Buy |
|